Ovide F. Pomerleau

Ovide F. Pomerleau

Ovide F. Pomerleau (born June 4, 1940) is an American psychologist who pioneered the application of biobehavioral principles in preventive medicine. He is best known for his work on self-management problems and addiction, focusing in particular on the biobehavioral, biological, and genetic bases of tobacco smoking and nicotine dependence.

Biography

Background and education

Pomerleau was born and grew up in Waterville, Maine, the son of Ovid Pomerleau, a physician and general surgeon, and Florence Pomerleau. He earned a B.A. (1962) in philosophy from Bowdoin College, followed by a M.S. (1965) in general psychology and Ph.D. (1969) in experimental psychology from Columbia University, where he trained in the laboratory of William N. Schoenfeld. In 1971 he completed postdoctoral training in clinical psychology at Temple University, where he worked with Philip H. Bobrove and Louis C. Harris.

Professional career

Pomerleau held a faculty appointment in the Temple University Department of Psychiatry from 1969 to 1972. During this time, he and his colleagues designed and tested a token economy at Philadelphia State Hospital at Byberry that extended earlier work on token economies in psychiatric settings by addressing the behavior not only of seriously mentally ill patients but also of paraprofessional staff.

From 1972 to 1979, Pomerleau served on the faculty of the University of Pennsylvania Department of Psychiatry, where in 1973 he and John Paul Brady founded the Center for Behavioral Medicine to develop interventions for weight management and the treatment of smoking and problem drinking, chronic behaviors associated with diminished quality of life, decreased longevity, and pathophysiological damage. The Center for Behavioral Medicine was the first to employ the term “behavioral medicine” to characterize the use of an integrated biological, behavioral, psychological, and social science perspective for understanding illness and health.[1] [2]

In 1979, Pomerleau joined the faculty of the University of Connecticut Department of Psychiatry, where he collaborated with L. Everett Seyler to demonstrate and quantitate, at the human level, the release of beta-endorphin and other hypophyseal hormones in response to nicotine administration.[3] Because of the role of endogenous opioids in promoting feelings of well-being and euphoria, these findings came under attack by the tobacco industry, which at the time maintained that tobacco was not addictive.[4]

From 1985 until his retirement in 2009, Pomerleau served on the faculty of the University of Michigan Department of Psychiatry and ran the Nicotine Research Laboratory, which conducted research on the subjective, physiological, and biochemical effects of smoking, and on the effects of pharmacological probes and laboratory stressors on measures of nicotine intake and withdrawal. He developed a "sensitivity model" of nicotine addiction based on animal and human research,[5] subsequently supported by observations that pleasurable or euphoric responses to nicotine during early smoking experimentation predict later addiction.[6] He also conducted research on the relationship of smoking and psychiatric disorders, and his team was the first to document and describe the link between smoking and Adult Attention Deficit Disorder.[7] He was an early proponent of the need for measured genetic research on smoking and nicotine addiction.[8]

Personal

In 1965, Pomerleau married Cynthia Stodola Pomerleau, subsequently his collaborator at the University of Michigan. The couple has two daughters, Julie Pomerleau (born 1968) and Aimée Pomerleau (born 1971).

Honors and awards

Selected publications

References

  1. ↑ Brief history of the origins of Behavioral Medicine. Kennerly RC.’’Index of Scholarly Psychology References on the Web: Health Psychology and Behavioral Medicine.’’ Retrieved 2012-05-30.
  2. ↑ Mindfulness and Acceptance in Behavioral Medicine. McCracken LM (Ed). Oakland, CA: New Harbinger Publications (2011), p. 5.
  3. ↑ “Smoking depicted as an addiction with many lures”, New York Times, Dec. 25, 1984. Retrieved 2012-08-08
  4. ↑ “Commentary: The addictive role of nicotine in tobacco use.“ Henningfield JE and Heishman SJ. Psychopharmacology (journal) 117:11-13 (1995). Retrieved 2012-08-12.
  5. ↑ http://www.cancercontrol.cancer.gov/tcrb/monographs/20/m20_entire.pdf National Cancer Institute. Phenotypes and Endophenotypes: Foundations for Genetic Studies of Nicotine Use and Dependence. Tobacco Control Monograph No. 20. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. NIH Publication No. 09-6366, August 2009, pp. 363-364. Retrieved 2012-08-12.
  6. ↑ “Nicotine sensitivity may lead to nicotine addiction.“ Chicago Tribune Dec. 12, 1993. Retrieved 2012-08-08.
  7. ↑ “Many smokers who can’t quit are mentally ill, a study finds” The New York Times. August 27, 1997. Retrieved 2012-08-10.
  8. ↑ “Individual differences in sensitivity to nicotine: Implications for genetic research on nicotine dependence.” Pomerleau OF. Behavior Genetics (journal) 25:161-177 (1995).
  9. ↑ “In the Limelight,” Medicine at Michigan. Retrieved 2012-08-10

External links

This article is issued from Wikipedia - version of the 5/26/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.